145691-59-4Relevant articles and documents
Oxidized graphitic carbon nitride as a sustainable metal-free catalyst for hydrogen transfer reactions under mild conditions
Bahuguna, Ashish,Choudhary, Priyanka,Dhankhar, Sandeep Singh,Krishnan, Venkata,Kumar, Ajay,Nagaraja, C. M.
, p. 5084 - 5095 (2020)
The development of green and sustainable transfer hydrogenation protocols without the use of expensive noble metals and toxic solvents is a challenging task. Herein, a highly stable, low-cost, metal-free heterogeneous catalyst, oxidized graphitic carbon nitride (O-GCN), has been developed, which exhibits efficient catalytic hydrogen transfer reactions of carbonyl compounds to corresponding alcohols under mild reaction conditions. The heterogeneous catalyst was synthesized by the chemical oxidation of graphitic carbon nitride (GCN) nanosheets, which results in the generation of carboxyl, hydroxyl and ketone groups over the GCN surface. These hydrophilic groups functionalized on the surface of O-GCN nanosheets act as catalytically active sites for the hydrogen transfer reactions of carbonyl compounds. A wide range of substrates was investigated for the hydrogen transfer reactions using 2-propanol both as a hydrogen donor and a solvent. The O-GCN nanosheets resulted in high yields and high turnover numbers (TON) demonstrating the versatile catalytic potential of the as-synthesized catalyst. The detailed optimization of the reaction parameters (temperature, time and catalyst amount) was performed, in addition to the calculation of green metric parameters. Moreover, the catalyst could be easily recovered and was used for five runs without any significant loss in catalytic activity. This study provides a green, sustainable, attractive, and useful methodology for the hydrogen transfer reactions of a wide range of carbonyl compounds.
IMIDAZOLIDINONE DERIVATIVES AS INHIBITORS OF PERK
-
Page/Page column 60, (2017/04/11)
The invention is directed to substituted imidazolidinone derivatives. Specifically, the invention is directed to compounds according to Formula I (I) wherein R1, R2, R3, R4, R5, R6, R7, X, Y1, Y2 and Z are defined herein. The compounds of the invention are inhibitors of PERK and can be useful in the treatment of cancer, pre-cancerous syndromes, as Alzheimer's disease, neuropathic pain, spinal cord injury, traumatic brain injury, ischemic stroke, stroke, Parkinson disease, diabetes, metabolic syndrome, metabolic disorders, Huntington's disease, Creutzfeldt-Jakob Disease, fatal familial insomnia, Gerstmann-Str?ussler-Scheinker syndrome, and related prion diseases, amyotrophic lateral sclerosis, progressive supranuclear palsy, myocardial infarction, cardiovascular disease, inflammation, organ fibrosis, chronic and acute diseases of the liver, fatty liver disease, liver steatosis, liver fibrosis, chronic and acute diseases of the lung, lung fibrosis, chronic and acute diseases of the kidney, kidney fibrosis, chronic traumatic encephalopathy (CTE), neurodegeneration, dementias, frontotemporal dementias, tauopathies, Pick's disease, Neimann-Pick's disease, amyloidosis, cognitive impairment, atherosclerosis, ocular diseases, arrhythmias, in organ transplantation and in the transportation of organs for transplantation. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting PERK activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
Photoinduced energy and electron transfer in phenylethynyl-bridged zinc porphyrin-oligothienylenevinylene-C60 ensembles
Urbani, Maxence,Ohkubo, Kei,Islam, D. M. Shafiqul,Fukuzumi, Shunichi,Langa, Fernando
supporting information; experimental part, p. 7473 - 7485 (2012/07/28)
Donor-bridge-acceptor triad (Por-2TV-C60) and tetrad molecules ((Por)2-2TV-C60), which incorporated C60 and one or two porphyrin molecules that were covalently linked through a phenylethynyl-oligothienylenevinyl
